Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PHF2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
FZD5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
H2AFY - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DLEU1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
FDX1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC1A4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PID1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DSN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MFAP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PAXIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPATS2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
YY1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MSH6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ATAD2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC20A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NUP50 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DCK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GLUD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SIPA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on